Affinity-Based Selectivity Profiling of an In-Class Selective Competitive Inhibitor of Acyl Protein Thioesterase 2

ACS Medicinal Chemistry Letters
2017.0

Abstract

Activity-based protein profiling (ABPP) has revolutionized the discovery and optimization of active-site ligands across distinct enzyme families, providing a robust platform for in-class selectivity profiling. Nonetheless, this approach is less straightforward for profiling reversible inhibitors and does not access proteins outside the ABPP probe's target profile. While the active-site competitive acyl protein thioesterase 2 inhibitor ML349 (Ki = 120 nM) is highly selective within the serine hydrolase enzyme family, it could still interact with other cellular targets. Here we present a chemoproteomic workflow to enrich and profile candidate ML349-binding proteins. In human cell lysates, biotinylated-ML349 enriches a recurring set of proteins, including metabolite kinases and flavin-dependent oxidoreductases that are potentially enhanced by avidity-driven multimeric interactions. Confirmatory assays by native mass spectrometry and fluorescence polarization quickly rank-ordered these weak off-targets, providing justification to explore ligand interactions and stoichiometry beyond ABPP.

Knowledge Graph

Similar Paper

Affinity-Based Selectivity Profiling of an In-Class Selective Competitive Inhibitor of Acyl Protein Thioesterase 2
ACS Medicinal Chemistry Letters 2017.0
Oxime esters as selective, covalent inhibitors of the serine hydrolase retinoblastoma-binding protein 9 (RBBP9)
Bioorganic & Medicinal Chemistry Letters 2010.0
Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL
Bioorganic & Medicinal Chemistry Letters 2021.0
Binding Ensemble Profiling with Photoaffinity Labeling (BEProFL) Approach: Mapping the Binding Poses of HDAC8 Inhibitors
Journal of Medicinal Chemistry 2009.0
Staurosporine tethered peptide ligands that target cAMP-dependent protein kinase (PKA): Optimization and selectivity profiling
Bioorganic & Medicinal Chemistry 2009.0
Testing the Promiscuity of Commercial Kinase Inhibitors Against the AGC Kinase Group Using a Split-luciferase Screen
Journal of Medicinal Chemistry 2012.0
Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited
Bioorganic & Medicinal Chemistry Letters 2018.0
Dabigatran and Dabigatran Ethyl Ester: Potent Inhibitors of Ribosyldihydronicotinamide Dehydrogenase (NQO2)
Journal of Medicinal Chemistry 2012.0
GRID/CPCA:  A New Computational Tool To Design Selective Ligands
Journal of Medicinal Chemistry 2000.0
Theoretical models of inhibitory activity for inhibitors of protein–protein interactions: targeting menin–mixed lineage leukemia with small molecules
MedChemComm 2017.0